{"podcast":{"title":"Neurology Minute","slug":"neurology-minute-15117","podcast_index_feed_id":15117,"rss_url":"https://neurologyminute.libsyn.com/rss","website_url":"https://www.aan.com/education-and-research/online-learning-programs/podcasts/neurology-minute-podcast","image_url":"https://static.libsyn.com/p/assets/3/0/c/3/30c3c82925660375e55e3c100dce7605/NM_PodcastIcon_1400x1400.png","author":"Anna Rehbein","episode_count":1956,"summary":"The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.","last_synced_at":"2026-06-25T18:20:17.428469+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117"},"episode":{"title":"Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1","slug":"maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1","published_at":"2026-04-29T08:30:00+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1","show_page_url":"https://stenobird.com/podcast/neurology-minute-15117","url":"https://neurologyminute.libsyn.com/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1","audio_url":"https://traffic.libsyn.com/secure/neurologyminute/03_April_29th_2026_nm_v2.mp3?dest-id=1085030","summary":"In part one of this series, Dr. Justin Abbatemarco and Dr. Benjamin P. Trewin discuss the major findings from his work. Read more about this abstract on the AAN website .","meta_description":"In part one of this series, Dr. Justin Abbatemarco and Dr. Benjamin P. Trewin discuss the major findings from his work. Read more about this abstract on t…","key_points":[],"chapters":[],"topics":[],"duration_seconds":257,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neurology-minute-15117/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}